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Background: Accessory pathway (AP) ablation is currently performed in
patients with a preexcitation syndrome (PS); natural follow-up is based on old
studies. The purpose of the study was to report data of untreated patients with
PS, studied 2 times at least one year of interval. 
Methods: 2 baseline electrophysiological study (EPS) were performed within
1 to 25 years of one another (mean 9.5±7) in 104 patients, 58 males, 46 females,
aged initially from 4 to 67 y (30±16), with overt PS. First EPS was indicated for
syncope (n=10), atrioventricular reentrant tachycardias (AVRT)(n=51), atrial
fibrillation (AF)(n=6), spontaneous malignant form (AF conducted at very high
rates over AP)(n=4) or for asymptomatic PS (n= 33). The protocol was similar,
performed in control state (CS) and after isoproterenol.
Results: At 2nd EPS, among patients studied for syncope at EPS1, 2 have still
syncope, 3 have AVRT, 1 has AF, 3 are asymptomatic. Among patients with
AVRT at EPS1, 38 (74.5%) have AVRT, 8 are asymptomatic, 3 had syncope, 3
has AF. Among patients with AF, 2 present with a malignant form, 2 had AVRT,
1 is asymptomatic. Among asymptomatic patients, 3 present with a malignant
form, 17 (53%) remain asymptomatic, 7 have AVRT, 4 have syncope, 1 has AF.
All AVRT or AF but 1 occurred in patients with inducible AVRT or AF at EPS1.
The higher rate conducted by AP was lower in CS and after isoproterenol at
EPS2 (166±80bpm, 191±90) than at EPS1 (191±67, 243±67)(p<0.01). AP refrac-
tory periods increased from 268±73ms to 283±62 in CS (p<0.03) and from
202±46 to 244±54ms after isoproterenol (p<0.03). AP has lost anterograde con-
duction properties in 28 patients. AVRT was induced in 5 of 27 asymptomatic
PS with initially negative EPS. Two patients with initially poor anterograde con-
duction over AP have a very rapid conduction over AP several years later.
Conclusions: We generally report an improvement of electrophysiological
data with the time; however AVRT induction remains present in 74.5% of
cases; unexpected changes may occur in 2% of patients considered initially at
low risk who developed a dramatic shortening of AP refractory period several
years after initial measurement. 
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Too often, tachycardias of elderly patients are medically treated without
evaluation of their mechanism. The purpose of the study was to look for the
influence of age on clinical and electrophysiological data and long-term
follow-up of patients with paroxysmal supraventricular tachycardia (SVT). 
Methods: SVT was induced in 1690 patients, 996 females, mean age
49±19 years referred for regular tachycardia. Clinical history, SVT-related
complications, echocardiography, results of electrophysiological study,
methods of treatment were collected. 
Results: 269 patients with SVT were aged from 70 to 97 years (group I),
188 from 70 to 79 (group IA) and 81 from 80 to 97 (group IB). Anticoagulants
were prescribed in 23 for an erroneous diagnosis of atrial tachycardia. They
were compared to 1421 patients <70 years (group II). Heart disease was more
frequent in group I (26%) (group IA:30%, group IB:18%) than in group II
(9%) (p<0.0001). Atypical and typical AV node reentrant tachycardia were
more frequent in group I (94%) than in group II (80%) and concealed acces-
sory pathway was less frequent in group I (6%, Group IA:7%, IB:5%) than in
group II (20%). SVT-related adverse events were more frequent in group I
(26%) (p<0.0001) (group IA:25%,group IB:29%) than in group II (11%).
During follow-up (3±3 years), SVT ablation was indicated more frequently in
group I (73%) (p<0.002) (group IA:73%, group IB:72%) than in group II
(62.5%). SVT ablation-related complications were more frequent in group
IB:7%) (p<0.011) than in group I (3.5%) or IA (4%). Late occurrence of atrial
fibrillation (AF) was more frequent in group IA (10%) than in group II (5%)
(p<0.04) (NS for the group IB (5%). Cardiac deaths were more frequent in
group I (6%) (group IA:4%, group IB: 7.5%) than in group II (2%) (p<0.001). 
Conclusions: SVT-related adverse presentation was frequent in elderly
patients. We recommend the evaluation of regular SVT’s because they can be
related to AVNRT/AVRT. Curative treatment of these tachycardias can be
done despite a risk of ablation-related major complications more frequent after
79 years and a risk of AF development and cardiac death higher in elderly
patients than in younger patients. 
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Background: Slow pathway radiofrequency ablation is used to treat atrio-
ventricular nodal re-entrant tachycardia (AVNRT), but some patients remain
symptomatic. The aim of study was to find predictive clinical factors of
arrhythmias recurrence in symptomatic patients after AVNRT ablation and
risk factors of AF occurrence.
Methods: Slow pathway ablation was performed in 929 patients with
AVNRT and aged 52±18 years. RF energy, 65°, 40 watts was delivered, until
AVNRT was not induced. 
Results: 94 patients were excluded because ablation failed. During follow-
up (mean 2.2±2 years), 136 (16%) had recurrence of symptoms. After invasive
and non-invasive studies, symptoms were related to a sinus tachycardia (n=39)
(5%)( group I), a tachycardia of other origin (atrial fibrillation (AF) (n=54)
(6%) (group II) or AVNRT recurrence (n=43) (5%) (group III); 699 patients
were asymptomatic (84%) (group IV). Group II was older (60±12 years) than
group III (51±20), I (33±15.5), IV (52±18)(p<0.001), less frequently female
(48%) than group I (85%), III (63%), IV (66%)( p<0.001) and had more fre-
quently history of AF (30%) than group I (3%), III (0%) and IV (3%). Other
factors as induction after isoproterenol, mechanism of AVNRT, history of
syncope, number of RF applications, were not different at univariate and
multivariate analysis. A score ≥3 based on age and history of AF (1 for age
45-60 years, 2 for age >60, 3 for history of AF) identified all symptomatic
patients with AF. A score 0 excluded patients with AF-related symptoms.
Patients with only sinus tachycardia and recurrent AVNRT can not be differ-
entiated except by a younger age, in case of sinus tachycardia.
Conclusions: Recurrence of symptoms after successful AVNRT ablation is
relatively frequent (16%), but recurrence of AVNRT is only present in 5% of
patients. A score ≥3 based on age and history of AF identified all patients at
risk of AF. Careful management is required in these patients.
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Measurement of accessory pathway (AP) refractory period (RP) is required
for the evaluation of preexcitation syndrome (PS). The purpose of study was
to evaluate the measurement of AP-RP by transesophageal electrophysiolo-
gical study (EPS) and intracardiac EPS.
